Return On Equity of MediXall Group, Inc. from 30 Jun 2015 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
MediXall Group, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2015 to 30 Sep 2024.
  • MediXall Group, Inc. Return On Equity for the quarter ending 30 Sep 2024 was 35%, a 67% decline year-over-year.
  • MediXall Group, Inc. annual Return On Equity for 2023 was 87%, a 71% decline from 2022.
  • MediXall Group, Inc. annual Return On Equity for 2022 was 303%.
  • MediXall Group, Inc. annual Return On Equity for 2021 was -2186%, a 58% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

MediXall Group, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2024 35% -73% -67% 01 Jul 2024 30 Sep 2024
Q2 2024 51% -78% -60% 01 Apr 2024 30 Jun 2024
Q1 2024 65% -113% -63% 01 Jan 2024 31 Mar 2024
Q4 2023 87% -216% -71% 01 Oct 2023 31 Dec 2023
Q3 2023 108% -374% -78% 01 Jul 2023 30 Sep 2023
Q2 2023 128% -940% -88% 01 Apr 2023 30 Jun 2023
Q1 2023 177% -5048% -97% 01 Jan 2023 31 Mar 2023
Q4 2022 303% +2488% 01 Oct 2022 31 Dec 2022
Q3 2022 482% +1850% 01 Jul 2022 30 Sep 2022
Q2 2022 1069% +2019% 01 Apr 2022 30 Jun 2022
Q1 2022 5226% +6044% 01 Jan 2022 31 Mar 2022
Q4 2021 -2186% -806% -58% 01 Oct 2021 31 Dec 2021
Q3 2021 -1368% -157% -13% 01 Jul 2021 30 Sep 2021
Q2 2021 -950% +719% +43% 01 Apr 2021 30 Jun 2021
Q1 2021 -819% +1110% +58% 01 Jan 2021 31 Mar 2021
Q4 2020 -1380% -387% -39% 01 Oct 2020 31 Dec 2020
Q3 2020 -1211% -489% -68% 01 Jul 2020 30 Sep 2020
Q2 2020 -1669% -936% -128% 01 Apr 2020 30 Jun 2020
Q1 2020 -1928% -1345% -230% 01 Jan 2020 31 Mar 2020
Q4 2019 -992% -187% -23% 01 Oct 2019 31 Dec 2019
Q3 2019 -722% +468% +39% 01 Jul 2019 30 Sep 2019
Q2 2019 -733% +1105% +60% 01 Apr 2019 30 Jun 2019
Q1 2019 -584% -2170% -137% 01 Jan 2019 31 Mar 2019
Q4 2018 -805% -1287% -267% 01 Oct 2018 31 Dec 2018
Q3 2018 -1190% -1431% -592% 01 Jul 2018 30 Sep 2018
Q2 2018 -1838% -1992% -1293% 01 Apr 2018 30 Jun 2018
Q1 2018 1586% +1482% +1427% 01 Jan 2018 31 Mar 2018
Q4 2017 482% +420% +683% 01 Oct 2017 31 Dec 2017
Q3 2017 242% +199% +473% 01 Jul 2017 30 Sep 2017
Q2 2017 154% +119% +341% 01 Apr 2017 30 Jun 2017
Q1 2017 104% +71% +220% 01 Jan 2017 31 Mar 2017
Q4 2016 62% +27% +76% 01 Oct 2016 31 Dec 2016
Q3 2016 42% +2% +5% 01 Jul 2016 30 Sep 2016
Q2 2016 35% -8% -19% 01 Apr 2016 30 Jun 2016
Q1 2016 33% 01 Jan 2016 31 Mar 2016
Q4 2015 35% 01 Oct 2015 31 Dec 2015
Q3 2015 40% 01 Jul 2015 30 Sep 2015
Q2 2015 43% 01 Apr 2015 30 Jun 2015

MediXall Group, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2023 87% -216% -71% 01 Jan 2023 31 Dec 2023
2022 303% +2488% 01 Jan 2022 31 Dec 2022
2021 -2186% -806% -58% 01 Jan 2021 31 Dec 2021
2020 -1380% -387% -39% 01 Jan 2020 31 Dec 2020
2019 -992% -187% -23% 01 Jan 2019 31 Dec 2019
2018 -805% -1287% -267% 01 Jan 2018 31 Dec 2018
2017 482% +420% +683% 01 Jan 2017 31 Dec 2017
2016 62% +27% +76% 01 Jan 2016 31 Dec 2016
2015 35% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.